137 related articles for article (PubMed ID: 30503067)
21. Changing trends in non-melanoma skin cancer in South Wales, 1988-98.
Holme SA; Malinovszky K; Roberts DL
Br J Dermatol; 2000 Dec; 143(6):1224-9. PubMed ID: 11122025
[TBL] [Abstract][Full Text] [Related]
22. Squamous-cell cancer of the skin in patients given PUVA and ciclosporin: nested cohort crossover study.
Marcil I; Stern RS
Lancet; 2001 Sep; 358(9287):1042-5. PubMed ID: 11589933
[TBL] [Abstract][Full Text] [Related]
23. [Clinical characteristics of malignant tumours originating in the external ear].
Gallegos-Hernández JF; Martínez-Méndez MÁ; Ábrego-Vázquez JA; Hernández-Sanjuan M; Minauro-Muñoz GG; Ortiz-Maldonado AL
Cir Cir; 2015; 83(6):473-7. PubMed ID: 26183026
[TBL] [Abstract][Full Text] [Related]
24. Epidemiology of cutaneous melanoma and non-melanoma skin cancer in Schleswig-Holstein, Germany: incidence, clinical subtypes, tumour stages and localization (epidemiology of skin cancer).
Katalinic A; Kunze U; Schäfer T
Br J Dermatol; 2003 Dec; 149(6):1200-6. PubMed ID: 14674897
[TBL] [Abstract][Full Text] [Related]
25. Risk of Non-melanoma Skin Cancer in Patients with Atopic Dermatitis Treated with Oral Immunosuppressive Drugs.
Garritsen FM; van der Schaft J; van den Reek JM; Politiek K; van Os-Medendorp H; van Dijk M; Hijnen DJ; de Graaf M; Bruijnzeel-Koomen CA; de Jong EM; Schuttelaar MA; Bruin-Weller MS
Acta Derm Venereol; 2017 Jun; 97(6):724-730. PubMed ID: 28218345
[TBL] [Abstract][Full Text] [Related]
26. Non-Melanoma Skin Cancer Risk Among Patients in the Psoriasis Longitudinal Assessment and Registry (PSOLAR).
deShazo R; Soltani-Arabshahi R; Krishnasamy S; Langley RG; Kalia S; Ståhle M; Langholff W; Goyal K; Fakharzadeh S; Galindo C; Srivastava B; Krueger G
J Drugs Dermatol; 2019 Oct; 18(10):1059-1060. PubMed ID: 31603636
[TBL] [Abstract][Full Text] [Related]
27. Cancer induction by immunosuppression in psoriasis after heavy PUVA treatment.
Molin L; Larkö O
Acta Derm Venereol; 1997 Sep; 77(5):402. PubMed ID: 9298142
[No Abstract] [Full Text] [Related]
28. Risks of cancer associated with long-term exposure to PUVA in humans: current status--1991.
Stern RS
Blood Cells; 1992; 18(1):91-7; discussion 98-9. PubMed ID: 1617196
[TBL] [Abstract][Full Text] [Related]
29. An increased risk of non-melanoma skin cancer during TNF-inhibitor treatment in psoriasis patients compared to rheumatoid arthritis patients probably relates to disease-related factors.
van Lümig PP; Menting SP; van den Reek JM; Spuls PI; van Riel PL; van de Kerkhof PC; Fransen J; Kievit W; de Jong EM
J Eur Acad Dermatol Venereol; 2015 Apr; 29(4):752-60. PubMed ID: 25229823
[TBL] [Abstract][Full Text] [Related]
30. Skin Cancer Risk (Nonmelanoma Skin Cancers/Melanoma) in Vitiligo Patients.
Rodrigues M
Dermatol Clin; 2017 Apr; 35(2):129-134. PubMed ID: 28317522
[TBL] [Abstract][Full Text] [Related]
31. Incidence and prevalence of non-melanoma skin cancer in Australia: A systematic review.
Perera E; Gnaneswaran N; Staines C; Win AK; Sinclair R
Australas J Dermatol; 2015 Nov; 56(4):258-67. PubMed ID: 25716064
[TBL] [Abstract][Full Text] [Related]
32. Comparison of the carcinogenic potential of trioxsalen bath PUVA and oral methoxsalen PUVA. A preliminary report.
Lindelöf B; Sigurgeirsson B; Tegner E; Larkö O; Berne B
Arch Dermatol; 1992 Oct; 128(10):1341-4. PubMed ID: 1417020
[TBL] [Abstract][Full Text] [Related]
33. Carcinogenic risks of psoralen UV-A therapy and narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review.
Archier E; Devaux S; Castela E; Gallini A; Aubin F; Le Maître M; Aractingi S; Bachelez H; Cribier B; Joly P; Jullien D; Misery L; Paul C; Ortonne JP; Richard MA
J Eur Acad Dermatol Venereol; 2012 May; 26 Suppl 3():22-31. PubMed ID: 22512677
[TBL] [Abstract][Full Text] [Related]
34. Total skin electron beam therapy followed by adjuvant psoralen/ultraviolet-A light in the management of patients with T1 and T2 cutaneous T-cell lymphoma (mycosis fungoides).
Quirós PA; Jones GW; Kacinski BM; Braverman IM; Heald PW; Edelson RL; Wilson LD
Int J Radiat Oncol Biol Phys; 1997 Jul; 38(5):1027-35. PubMed ID: 9276369
[TBL] [Abstract][Full Text] [Related]
35. Incidence of skin cancers during 5-year follow-up after stopping antioxidant vitamins and mineral supplementation.
Ezzedine K; Latreille J; Kesse-Guyot E; Galan P; Hercberg S; Guinot C; Malvy D
Eur J Cancer; 2010 Dec; 46(18):3316-22. PubMed ID: 20605091
[TBL] [Abstract][Full Text] [Related]
36. Non-melanoma skin cancer: ten years of cancer-registry-based surveillance.
Kaldor J; Shugg D; Young B; Dwyer T; Wang YG
Int J Cancer; 1993 Apr; 53(6):886-91. PubMed ID: 8473047
[TBL] [Abstract][Full Text] [Related]
37. The carcinogenic risk of treatments for severe psoriasis. Photochemotherapy Follow-up Study.
Stern RS; Laird N
Cancer; 1994 Jun; 73(11):2759-64. PubMed ID: 8194017
[TBL] [Abstract][Full Text] [Related]
38. The epidemiology of skin cancer.
Diepgen TL; Mahler V
Br J Dermatol; 2002 Apr; 146 Suppl 61():1-6. PubMed ID: 11966724
[TBL] [Abstract][Full Text] [Related]
39. Risk factors for non-melanoma skin cancer in kidney transplant patients in a Spanish population in the Mediterranean region.
Bernat García J; Morales Suárez-Varela M; Vilata JJ; Marquina A; Pallardó L; Crespo J
Acta Derm Venereol; 2013 Jul; 93(4):422-7. PubMed ID: 23303600
[TBL] [Abstract][Full Text] [Related]
40. Non-melanoma skin cancer in Portuguese kidney transplant recipients - incidence and risk factors.
Pinho A; Gouveia M; Cardoso JC; Xavier MM; Vieira R; Alves R
An Bras Dermatol; 2016; 91(4):455-62. PubMed ID: 27579740
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
